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Abstract
Summary Hip fracture patients can benefit from nutritional
supplementation during their recovery. Up to now, cost-
effectiveness evaluation of nutritional intervention in these
patients has not been performed. Costs of nutritional inter-
vention are relatively low as compared with medical costs.
Cost-effectiveness evaluation shows that nutritional inter-
vention is likely to be cost-effective.
Introduction Previous research on the effect of nutritional
intervention on clinical outcome in hip fracture patients
yielded contradictory results. Cost-effectiveness of nutri-
tional intervention in these patients remains unknown. The
aim of this study was to evaluate cost-effectiveness of
nutritional intervention in elderly subjects after hip fracture
from a societal perspective.
Methods Open-label, multi-centre randomized controlled
trial investigating cost-effectiveness of intensive nutritional
intervention comprising regular dietetic counseling and oral
nutritional supplementation for 3 months postoperatively.
Patients allocated to the control group received care as
usual. Costs, weight and quality of life were measured at
baseline and at 3 and 6 months postoperatively. Incremental
cost-effectiveness ratios (ICERs) were calculated for weight
at 3 months and quality adjusted life years (QALYs) at
6 months postoperatively.
Results Of 152 patients enrolled, 73 were randomized to the
intervention group and 79 to the control group. Mean costs
of the nutritional intervention was 613 Euro. Total costs and
subcategories of costs were not significantly different be-
tween both groups. Based on bootstrapping of ICERs, the
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nutritional intervention was likely to be cost-effective for
weight as outcome over the 3-month intervention period,
regardless of nutritional status at baseline. With QALYs as
outcome, the probability for the nutritional intervention
being cost-effective was relatively low, except in subjects
aged below 75 years.
Conclusion Intensive nutritional intervention in elderly hip
fracture patients is likely to be cost-effective for weight but
not for QALYs. Future cost-effectiveness studies should
incorporate outcome measures appropriate for elderly
patients, such as functional limitations and other relevant
outcome parameters for elderly.
Keywords Cost-effectiveness . Elderly . Hip fracture .
Nutritional support . Quality of life
Introduction
In The Netherlands, as well as in other countries, the inci-
dence of hip fractures in the elderly is high, and it is
expected to increase in the nearby future. Hip fractures are
one of the most common reasons for hospital admission and
transfers to nursing facilities in the elderly [1]. After hip
fracture, only 37% of the patients will return to their pre-
fracture functional status leading to high health care costs
and a major burden on health care utilization [2]. Not only
costs resulting from a hip fracture during hospital stay are
relevant, but also long-term costs such as recovery in a
rehabilitation clinic, the need for home care, and the in-
creased burden on informal care givers which may play an
even more important role [2, 3].
At the time of hospital admission for surgical treatment of
their hip fracture, hip fracture patients are reported to be
malnourished, and the nutritional status can deteriorate fur-
ther during hospital admission because of a spontaneous
reduction in food intake due to lack of appetite or nausea
[4–9]. Malnutrition in hip fracture patients is reported to be
associated with impaired muscle function, disability, loss of
independency, decreased quality of life, delayed wound
healing, higher complication rate, prolonged rehabilitation
time, and increased mortality rate [7, 8, 10–17]. Both hip
fracture patients and malnourished patients in general have
an increased use of health care as compared with well-
nourished and non-fracture patients, and it is expected that
it would result in higher health care costs [18–21]. Early
treatment of malnutrition is of vital importance to minimize
losses and to achieve rapid weight recovery after hip
fracture.
In the past decades, several studies have been conducted
to determine the effectiveness of nutritional supplementation
on length of stay, postoperative complications, mortality, nu-
tritional status and functional status. Furthermore, within the
past decades, economic evaluations have gained more and
more attention, and their importance has increased because
of the continuous rising health care expenses and the limited
budgets available. As a consequence, new or additional treat-
ments should not only have to be effective but also cost-
effective. Previous research on costs and cost-effectiveness
of nutritional support or intervention is scarce. A few studies
have shown that health care costs can be reduced by nutri-
tional support in malnourished elderly [20, 22, 23]. Kruizenga
et al. [24] reported that nutritional screening and treatment of
malnourished patients at an early stage of hospitalization is
cost-effective.
Although several studies have shown the effectiveness of
nutritional support in elderly hip fracture patients, none of
these studies have incorporated an economic or cost-
effectiveness evaluation. Therefore, the aim of the present
study was to investigate the cost-effectiveness of an inten-
sive dietary intervention comprising combined dietetic
counseling and oral nutritional supplementation, as com-
pared with usual nutritional care in elderly subjects after




Eligible were patients admitted for surgical treatment of hip
fracture, aged ≥55 years [25]. Patients were excluded if they
had a pathological or periprosthetic fracture; a disease of
bone metabolism (e.g. M Paget, M Kahler, hyperparathy-
roidism); an estimated life expectancy <1 year due to un-
derlying disease; if they used an oral nutritional supplement
before hospital admission; if they were unable to speak
Dutch, lived outside the region or had been bedridden
before their hip fracture. Patients were also excluded if they
had dementia or were cognitively impaired, defined as a
score of <7 on the Abbreviated Mental Test, as assessed
before inclusion [26].
Design
The present economic evaluation was embedded in an open-
label parallel multi-centre, randomized controlled trial on
the effectiveness of nutritional intervention in elderly sub-
jects after a hip fracture [25]. The economic evaluation was
performed from a societal perspective using a time horizon
of 6 months.
For patient recruitment, we made a daily inventory of all
hip fracture patients admitted to the surgical and orthopedic
wards of Maastricht University Medical Centre (Maastricht),
Atrium Medical Centre (Heerlen) and Orbis Medical Centre
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(Sittard). Eligible patients who met the inclusion criteria were
invited to participate, and written informed consent was
obtained within 5 days after surgery. After informed consent
and baselinemeasurements, patients were randomized accord-
ing to a concealed computer-generated random-number se-
quence list after pre-stratification for hospital, gender and age
(55–74 vs. ≥75 years) with an allocation ratio of 1:1. After
randomization, all patients were visited by a study dietician
who evaluated patients’ nutritional intake by a 24-h recall.
Then, patients allocated to the intervention group received
dietetic counseling and an oral nutritional supplement as
needed, for 3 months after fracture, whereas patients in the
control group received usual nutritional care. Costs and out-
come measurements were assessed at 3 and 6 months postop-
eratively [25]. Patients were discharged from the hospital
according to standard care, either to a rehabilitation clinic or
to the patient’s home with home care, or to the nursing home
or elderly home where they had lived there before hospitali-
zation. The study was approved by the Medical Ethical Com-
mittee of Maastricht University Hospital and Maastricht
University and conducted according to the Declaration of
Helsinki.
Nutritional intervention
Patients in the intervention group received a combination of
frequent dietetic counseling and consumption of a multi-
nutrient oral nutritional supplement (ONS), starting during
hospital admission and continued in the rehabilitation centre
and/or at home, until 3 months after hip fracture surgery.
A dietician visited each patient twice during their hospital
stay. At the first visit, the dietician took a 24-h recall of the
patient’s diet during hospitalization. To optimize normal
food intake, all patients received an energy- and protein-
enriched diet, and recommendations were given with regard
to choice, quantity and timing of food products. In addition,
patients were advised to consume two bottles of ONS daily
in-between the main meals. The ONS was a milk-protein
based, or a yoghurt- or juice-style supplement (Cubitan,
Nutridrink Yoghurt style, or Nutridrink Juice style, N.V.
Nutricia, Zoetermeer, The Netherlands) providing 2.1 MJ
(500 kcal) and 40 g of protein per 500 ml. Furthermore, the
dietician made arrangements to solve any problems, e.g.
feeding difficulties, in collaboration with the hospital medical
and nursing staff.
At the second visit during hospitalization, 7–8 days after
surgery, the dietician evaluated food intake and the consump-
tion of the ONS using a 24-h recall and gave individually
tailored advice to optimize dietary intake. Furthermore, the
transfer of the patient to the rehabilitation centre or the
patient’s home was prepared by evaluating the patient’s phys-
ical restrictions with regard to nutritional care, i.e. purchasing
food products and the preparation of meals, and by making
arrangements to enable adequate food intake, e.g. support of
informal caregivers and delivery of information on meal
services.
After hospital discharge, the dietician visited each patient
three times (1, 2 and 6 weeks after discharge) at the patient’s
home or in the rehabilitation centre (whatever was applicable)
in order to evaluate dietary intake including the intake of the
ONS, to evaluate possible bottlenecks in nutritional care at
home (e.g. shopping, cooking) and to give dietary advice as
needed. In addition, in-between these home visits, weekly
telephone calls were made (3, 4, 5, 8 and 10 weeks after
discharge) to evaluate dietary intake (including the ONS) by
24-h recall. If necessary, a telephone call was replaced by a
home visit.
Usual care
Patients allocated to the control group received usual care as
provided in the hospital, rehabilitation clinic or at home, i.e.
dietetic care or nutritional supplements were only provided
on demand of the medical doctor in charge. In the control
group, ten patients (13%) received ONS and 18 patients
(23%) received dietetic counseling.
Economic evaluation
Effect measures
Weight At baseline, self-reported weight was used, because
patients were not able to stand on a weighing scale because
of hip fracture. At 3 months postoperatively, weight was
measured using an electronic weighing scale (Seca 862,
Seca Ltd, Birmingham, UK). The difference in weight in
kilograms between baseline and 3 months postoperatively
was calculated and used to evaluate the effectiveness of the
nutritional intervention.
Quality adjusted life years Quality of Life was estimated at
baseline and at 3 and 6 months postoperatively using the
Dutch version of EuroQoL (EQ-5D-3 L) [27–29]. In the
EuroQoL, the patient was asked to make a statement on the
degree of problems (no problem, some problems or major
problems) he/she experienced on the dimensions of mobility,
self-care, usual activities, pain or discomfort and anxiety or
depression. The degree of problems on each dimension were
combined to a health state. Based on these health states,
utilities were calculated based on the social tariff by Dolan
because this is the internationally accepted standard [30].
Utilities are the preferences that individuals or the society
may have for a particular set of health outcomes. These
utilities were used to calculate Quality Adjusted Life Years
(QALYs), which are defined as ‘a measure of a person’s length
of life weighted by a valuation of their health related quality of
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life’ [31]. QALYs are used to make a comparison between
the effects of different treatments and to evaluate cost-
effectiveness of interventions. The value of the QALY
can range from below zero, representing the worst possi-
ble health state, up to 1, representing the best possible
health state.
Cost measures
Medical and non-medical costs were measured at baseline
and at 3 and 6 months postoperatively using a standardized
3-month retrospective patient costing questionnaire. Patients
were asked to report the frequency and location of consul-
tation with the general practitioner, physiotherapist and
other paramedical care givers, as well as professional home-
care for assistance with activities of daily living and house-
hold activities of daily living, and assistant devices and
medical aids. Medication was registered from the patient’s
medical chart, the medication list as provided by the general
practitioner or pharmacy, supplemented by registration of
medication packages. Length of stay in hospital, rehabilita-
tion clinic, nursing home and home for the elderly were
calculated using admission and discharge dates. The number
and duration of face-to-face visits and telephone calls were
calculated using the dietician’s time registries and used to
calculate the costs of a face-to-face visit and telephone call.
The quantity of the ONS was calculated based on the num-
ber of ONS as advised by the dietician.
We assessed nutritional intervention costs, health-care-
related costs and patient and family costs. Nutritional inter-
vention costs were defined as the costs of the dietetic
counseling by the dietician (face-to-face visits and telephone
calls) and nutritional supplementation (oral nutritional sup-
plements and tube feeding). Health-care-related costs were
hospital-related costs (hospital admissions and outpatient
specialist care), other in-patient-related costs (admissions
to rehabilitation clinic, nursing home or home for the elderly
and day centre activities), general practitioners, paramedical
care (physiotherapy, occupational therapy, other alternative
therapies), professional home care, assistant devices and
medical aids and prescribed and over-the-counter medica-
tion. Patient and family costs included the costs of home
adjustments, paid domestic help and meal services. Produc-
tivity costs were considered irrelevant for this population
because 89% of the patients in the control group and 96% of
the patients in the intervention group were retired; therefore,
these costs were not included in the calculation.
To calculate the costs, the volumes of each cost category
were multiplied by the cost price of each cost category. Cost
prices, presented in Euros, were based on the “Dutch manual
for costing: methods and standard costs for economic evalua-
tions in healthcare” for the year 2010 [32]. Standardized cost
prices were used where available, or else real costs or tariffs
were used to estimate the costs. Medication costs were calcu-
lated using prices based on the Defined Daily Dose which is
defined by the Health Care Insurance Board as the assumed
average maintenance dose per day for a drug used for its main
indication in adults [33, 34]. Prices of paid domestic help were
based on tariffs for unpaid work. With respect to costs of
hospital admissions, the cost price of a non-teaching hospital
was used because hip fracture surgery does not require the
expertise of a teaching hospital, and the Maastricht University
Medical Centre has both the function of a non-teaching and
teaching hospital. Costs of surgery were not included in the
cost calculation because previous research by Haentjens et al.
[35] showed that the costs of the different types of surgery are
comparable.
Incremental cost-effectiveness ratios, cost-effectiveness
planes and cost-effectiveness acceptability curves
To evaluate cost-effectiveness, incremental cost-effectiveness
ratios (ICERs) were calculated. ICERs were calculated by
dividing the difference in the mean costs (between two treat-
ments or interventions) by the differences in the mean out-
comes. In this study, ICERs were calculated for weight change
and for QALYs. The ICERs were interpreted as the incremen-
tal cost per unit of additional outcome [29, 36].
These ICERs were plotted in a cost-effectiveness plane
(CEP), in which the x-axis showed the difference in effect
between the interventions and the y-axis the differences in
costs between the interventions [29, 36, 37]. In the CEP,
four quadrants were shown; ICERs located in the North East
(NE) indicated that the intervention was more effective and
more costly as compared with usual care. ICERs in the
South East (SE), the dominant quadrant, indicated that the
intervention is more effective and less costly. ICERs in the
South West (SW) indicated that the intervention was less
effective and less costly, and ICERs located in the North
West (NW) indicated that the nutritional intervention was
less effective but more costly.
Based on the CEPs, cost-effectiveness acceptability
curves (CEAC) were plotted [29, 36–38]. In the CEAC,
the probability that the nutritional intervention is more
cost-effective as compared with the usual care (y-axis) was
presented for several ceiling ratios (x-axis), which were
defined as the amount of money the society is willing to
pay to gain one unit of effect [29, 36–38]. Within The
Netherlands, the value the society is willing to pay to gain
one QALY ranges from 20,000 to 80,000 Euro, depending
on the severity of the disease [39].
Sensitivity analyses
Sensitivity analyses were performed for age categories (55–
74 vs. ≥75 years) because elderly patients can have more co-
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morbidities and postoperative complications as compared
with younger patients.
Sensitivity analyses were also performed for patients
classified according to their risk of malnutrition at baseline,
as measured by the Mini Nutritional Assessment (MNA).
The MNAwas developed for elderly people and includes 18
items grouped in four categories: anthropometric assessment
(including BMI, weight loss, arm circumference and calf
circumference); general assessment of lifestyle, medication
use, mobility, presence of signs of depression or dementia);
short dietary assessment (number of meals, food and fluid
intake, autonomy of feeding) and subjective assessment
(self perception of health and nutrition) [40, 41]. A score
of ≥24 indicates no malnutrition; a score between 17 and
23.5 indicates being at risk of malnutrition, and a score less
than 17 indicates malnutrition. For this purpose, the group
malnutrition and the group at risk of malnutrition are com-
bined and compared with the group no malnutrition.
Statistical analysis
Data were analyzed using SPSS version 15 and Excel 2003
and based on the intention-to-treat principle. Missing values
for the EuroQoL at 6 months postoperatively were imputed by
last observation carried forward. If volume date were missing
to calculate the costs, these missing data were replaced by
individual means of valid volume data before multiplying the
volumes by the cost prices. Costs were presented as means
and standard deviations, and Mann–Whitney U tests were
used to test for significant differences in costs between the
intervention and control group. The robustness of the cost
analyses was also tested by bootstrapping (1,000×). Further-
more, bootstrapping (5,000×) was used to calculate the uncer-
tainty around the cost-effectiveness ratios, and CEPs and
CEACs were plotted [29, 36–38]. Sensitivity analyses were
performed for age categories (55–74 vs. ≥75 years) and for the
risk of malnutrition at baseline (at risk of malnutrition and
malnutrition vs. nomalnutrition). Bootstrappingwas also used
to calculate the uncertainty around the ICERs resulting from
the sensitivity analyses, and CEPs and CEACs were also
plotted.
Results
From July 2007 until December 2009, a total of 1,304 hip
fracture patients were admitted to the surgical and orthope-
dic wards of the participating hospitals and screened for
eligibility. Of the screened patients, 895 (69%) did not meet
the inclusion criteria, mainly due to cognitive impairment
(52%). Two-hundred fifty-seven (20%) patients refused to
participate. Of the resulting 152 patients who gave informed
consent, 73 were randomly allocated to the intervention
group and 79 to the control group. During the 3-month
intervention period, seven patients (four, intervention; three,
control) passed away, and seven patients (three, interven-
tion; four, control) withdrew their participation, resulting in
138 assessable patients (68 intervention, 72 control) at
3 months. During the follow-up (3–6 months after surgery),
four patients (two intervention, two control) passed away,
and three patients (one, intervention; two, control) withdrew
their participation, resulting in 63 patients in the intervention
group and 68 patients in the control group who completed
follow-up.
At baseline, the intervention and control group were
comparable with respect to gender and age. In both groups,
the majority of the patients sustained a fracture of the medial
neck of the femur. In the intervention group, more patients
had received gamma nail, and fewer patients had received
hemi-arthroplasty as compared with the control group
(Table 1). After hospitalization, in the intervention group
as well as in the control group, 42 patients were discharged
to a rehabilitation clinic. At baseline, 37% of the patients in
the intervention group were malnourished or at risk of
malnutrition as compared with 48% of the patients in the
control group. Medical costs measured at baseline over a
3-month period, before hip fracture, were comparable be-
tween both groups (data not shown).
Costs
As shown in Table 2, the mean cost of the nutritional
intervention per patient in the intervention group was
613 Euro. Several patients in the control group also received
dietetic counseling and ONS, with mean cost of 88 Euro
(p00.000). The additional costs of the nutritional interven-
tion were only 3% of the total costs and were thus relatively
low as compared with other health-care-related costs and
patient- and family-related costs. Total health care costs,
patient and family costs, as well as the subcategories of




The intervention effect for weight, defined as the difference
in change between the intervention and control group from
baseline to 3 months postoperatively has a statistically sig-
nificant positive value, meaning that the patients in the
intervention group gained more weight as compared with
patients in the control group. The estimated intervention
effect from baseline to 3 months postoperatively was
1.91 kg (95% CI, 0.60–3.22; p00.005). The ICER for total
societal costs per kilogram weight increase was 241 Euro.
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As presented in Table 3, the overwhelming majority of the
dots in the CEP were located in the NE and SE quadrant.
The ICERs located in the NE quadrant represent ratios
indicating that the nutritional intervention was more costly
and more effective as compared with usual care. The ICERs
located in the SE represent ratios indicating that the nutri-
tional intervention was less costly and more effective as
compared with usual care. The CEAC (Fig. 1) indicates that,
with a willingness to pay of 5,000 Euro, the probability that
the nutritional intervention was cost-effective based on its
total societal costs per kilogram weight was as high as 98%.
Even at a willingness to pay € 2,500, the intervention was
still ∼70% likely to be cost-effective.
QALYs as outcome
At 6 months postoperatively, the intervention effect for
QALYs was not statistically significant. The estimate of
the intervention effect for change in QALYs was −0.02
(95% CI, −0.12–0.08; p>0.05). The ICER for total societal
costs per QALY was 36,943 Euro. As presented in Table 3,
the majority of the dots in the CEP based on total societal
costs per QALY were located in the NE and SE quadrants.
The ICERs located in the NE quadrant represented ratios
indicating that the nutritional intervention was more costly
and more effective as compared with usual care. The ICERs
located in the SE represented ratios indicating that the
nutritional intervention was less costly and more effective
as compared with usual care. The CEAC (Fig. 2) showed
that, with a willingness to pay of 20,000 Euro per QALY, the
probability that the nutritional intervention was cost-effective
based on its total societal costs per QALY was 45%. If the
willingness to pay is 80,000 Euro per QALY, the probability
that the intervention is cost-effective increased to 60%.
Sensitivity analyses
As cost-effectiveness of nutritional intervention may depend
on nutritional status and age (co-morbidities and postoperative
complications tend to increase with age), sensitivity analyses
were performed by stratifying our population for age (55–74
vs. ≥75 years) and nutritional status (malnutrition+risk of
malnutrition vs. no malnutrition, according to the MNA). In
Table 3, ICERs and the distribution of the ICERs on the CEP
are presented for these sensitivity analyses, both for weight
and QALYs as outcomes.
Table 1 Baseline characteristics
aMini Nutritional Assessment
Intervention group Control group
(n073) (n079)
n (%) n (%)
Sex
Female 54 (74) 54 (68)
Male 19 (26) 25 (32)
Age 79 (55–93) 78 (57–94)
Type of residence before fracture
Home 63 (86) 66 (83)
Nursing home 2 (3) 4 (5)
Home for the elderly 8 (11) 7 (9)
Rehabilitation clinic/hospital 0 (0) 2 (3)
Fracture type
Medial neck 36 (49) 45 (57)
Pertrochanteric 32 (44) 33 (42)
Subtrochanteric 5 (7) 1 (1)
Type of surgery
Gamma nail 37 (51) 24 (30)
Dynamic hip screw 6 (8) 11 (14)
Hemiarthroplasty 19 (26) 30 (38)
Total hip replacement 4 (5) 7 (9)
Three cannulated screws 7 (10) 6 (8)
Femoral nail 0 (0) 1 (1)
MNAa
No malnutrition 46 (63) 41 (52)
At risk of malnutrition or malnourished 27 (37) 38 (48)
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In Fig. 3, the probability that the nutritional intervention
was cost-effective with respect to weight is shown for
patients aged 55–74 years and patients aged ≥75 years. In
older patients, the probability that the nutritional interven-
tion was cost-effective was 100% if the society would be
willing to pay 5,000 Euro or more for 1 kg weight gained. In
younger patients, the probability that the intervention was
cost-effective was considerably lower (40–44%). As also
shown in Fig. 3, in malnourished patients and well-
nourished patients, the probability that the nutritional inter-
vention was cost-effective were 100% and 90%, respectively,
if the society is willing to pay 5,000 Euro or more for 1 kg
weight gain. With a willingness to pay of 2,500 Euro, these
percentages would be 90% and ∼50%, respectively, for mal-
nourished and well-nourished patients.
With respect to QALYs, if the nutritional intervention
was targeted to patients aged between 55 and 74 years, with
a willingness to pay of 20,000 Euro, the probability that the
Table 3 Cost-effectiveness analyses for weight difference and QALY
Participants Distribution on cost-effectiveness plane
Intervention Control ICERa NEb% SEc% SWd% NWe%
Weight
Weight base case 65 72 241 56 43 0 0
55–74 years 22 27 −2,788 27 17 27 29
75 years and above 43 45 149 56 44 0 0
No malnutritionf 42 38 2,349 93 7 0 0
(At risk of) malnourishedf 23 34 −1,404 18 82 0 0
QALYg
QALY base case 62 69 36,943 42 31 5 22
55–74 years 20 28 −4,880 40 60 0 0
75 years and above 42 41 −104,521 22 13 12 52
No malnutritionf 40 39 60,300 74 14 0 12
(At risk of) malnourishedf 22 30 −67,577 14 10 12 64
a Incremental cost-effectiveness ratio
b North East quadrant: the intervention was more effective and more costly as compared to usual care
c South East quadrant: the intervention was more effective and less costly as compared to usual care
e North West quadrant: the intervention was less effective and more costly as compared to usual care
d South West quadrant: the intervention was less effective and less costly as compared to usual care
f According to Mini Nutritional Assessment (MNA)






























Ceiling ratio willingness to pay ( )
Fig. 1 Cost-effectiveness acceptability curve presenting the probabil-
ity that the nutritional intervention is cost-effective (y-axis) for weight




























Ceiling ratio willingess to pay ( )
Fig. 2 Cost-effectiveness acceptability curve presenting the probabil-
ity that the nutritional intervention is cost-effective (y-axis) for QALY,
given various ceiling ratios for willingness to pay (x-axis)
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intervention was cost-effective was 85%, compared with only
26% in patients aged 75 years and above (Fig. 4). If the
willingness to pay is 80,000 Euro for one QALY, the proba-
bility for the nutritional intervention to be cost-effective in the
younger group increases to 98% while, in the older group, the
probability remains the same. As also shown in Fig. 4, at a
willingness to pay 20,000 Euro for one QALY, the probability
that the nutritional intervention was cost-effective were 20%
in malnourished patients and ∼25% in well-nourished
patients. With increasing willingness to pay, the probability
that the intervention was cost-effective remained similar in
malnourished patients whereas, in well-nourished patients, the
probability that intervention was cost-effective increased up
to ∼60% at a willingness to pay 80,000 Euro.
Discussion
Nutritional intervention in elderly hip fracture patients has
been proposed as an approach to improve clinical outcome.
Despite several decades of research, the overall evidence for
the effectiveness of ONS in elderly hip fracture patients with
respect to length of stay and functional outcome is limited
[42], and no thorough economic evaluation of nutritional
intervention in elderly subjects after hip fracture has been
performed so far.
In the present study, we assessed the cost-effectiveness of
an intensive nutritional intervention combining frequent
dietetic counseling and ONS for 3 months postoperatively
in elderly hip fracture patients. Results showed that the
direct costs of the nutritional intervention were low—
613 Euro per treated patient. Total health care costs, patient
and family costs, as well as subcategories of these costs
were similar in the intervention and control group. Results
showed that the nutritional intervention was likely to be
cost-effective for weight increase during the intervention
period (3 months) in the total study population. Sensitivity
analyses with stratification for nutritional status showed that
the cost-effectiveness for weight as outcome was especially










































the probability that the
nutritional intervention is
cost-effective (y-axis), given
various ceiling ratios for
willingness to pay (x-axis)
with respect to weight increase.
Sensitivity analyses performed
for age groups and nutritional
status at baseline, according











































the probability that the
nutritional intervention is
cost-effective (y-axis), given
various ceiling ratios for
willingness to pay (x-axis) with
respect to QALY. Sensitivity
analyses performed for age
groups and nutritional status at
baseline, according to the Mini
Nutritional Assessment (MNA)
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high) in well-nourished patients. If the nutritional inter-
vention would be targeted to elderly patients (≥75 years),
the probability that the intervention was cost-effective
was also high. This was in marked contrast with younger
patients (55–74 years), where cost effectiveness was <50%,
possibly due to the fact that younger patients generally
have a better general condition than elderly patients, so
that nutritional intervention will have less effect on their
weight.
With respect to QALY, the probability for the interven-
tion to be cost-effective was relatively low for the total
population and subgroups; however, the probability that
the nutritional intervention was cost-effective with respect
to QALY was highest (60–90% depending on willingness to
pay) in younger patients (55–74 years).
Our results confirm previous studies indicating that the
costs of nutritional intervention are extremely low (in our
case, less than 3%) compared with regular health care costs
such as hospital costs [20, 22–24, 43, 44]. Previous research
in malnourished patients living in the community and in a
heterogeneous group of malnourished patients admitted to a
mixed medical and surgical ward indicated that nutritional
intervention with oral nutritional supplementation alone or
combined with dietetic counseling was cost-effective with
regard to length of stay [24].
We found that, in hip fracture patients, the probability of
the nutritional intervention to be cost-effective with regard
to QALY as outcome was relatively low in the older age
group of ≥75 years. Of note, older patients more often live in
nursing homes even before the fracture, and they tend to
have more co-morbidities for which medical treatment is
needed; both these factors may overrule the potential cost-
reduction induced by the nutritional intervention. Also, after
hip fracture, older and malnourished patients may have more
postoperative complications and hospital re-admissions as
compared with younger and well-nourished patients. As also
noted in the literature, medical costs do not seem to be asso-
ciated with the type of surgical procedure but are mainly
determined by increasing age, living in an institution and the
presence of co morbidity [21, 38, 41]. Finally, home-dwelling
older patients often live alone, which may also result in a
higher requirement of professional care as compared with
patients living with their partner.
We used a time horizon of 6 months because weight gain
or weight maintenance is especially relevant in the vulner-
able period after hip fracture, since patients with a poor
nutritional status are prone to develop postoperative com-
plications which mostly occur in the first few weeks after
hip fracture surgery. In addition, the period of 6 months was
chosen because the overwhelming majority of medical costs
are made in the first 3 months after hip fracture due to
hospitalization, hip fracture surgery, patients’ stay in reha-
bilitation clinic, their visits to the general practitioner and
medical specialist and the treatment of postoperative
complications.
It is important to note here that, even though QALYs are
often used in cost-effectiveness analyses, this may not be an
ideal outcome measure for evaluating effectiveness and
cost-effectiveness in elderly patients and in nutritional inter-
vention studies [20, 45]. In the elderly, improvement in
nutritional intake and weight may be more clinically rele-
vant, as weight recovery is of vital importance as a basis for
overall recovery during the vulnerable period after hip frac-
ture. Also, it may be noted that weight gain is easier to
achieve by nutritional intervention than improvement in
quality of life, which depends on many other factors than
just nutritional status. Moreover, an improvement in weight
is necessary to maintain physical activity and cognitive
status of the hip fracture patient. In addition, quality of life
and resulting QALYs are not only determined by nutrition,
but other factors such as loneliness, social support, pain and
mobility. Although pain and functional status are included in
the EuroQoL 3 level, this questionnaire may not be suffi-
ciently sensitive to detect small differences in quality of life
in elderly individuals. Very recently, a new version of the
EuroQoL was developed with five response categories. Fu-
ture research should be performed to detect if the EuroQoL
5 level is sensitive enough to detect small changes in quality
of life in the elderly.
Several limitations should be noted. First, although we
excluded cognitive impaired patients, volumes of health
care consumption might have been influenced by cognitive
status of the patients, and therefore these volumes might be
over- or underestimated by the patients. Second, the eco-
nomic analyses were not adjusted for baseline differences
between the intervention and control group. Although costs
at baseline were similar in both groups, there was a lower
proportion of malnourished patients in the intervention
group compared with the control group (37% vs. 48%),
which might have influenced the overall analyses. However,
as cost-effectiveness ratios remained similar in our analyses
stratified by malnutrition (yes vs. no), we think this has not
influenced our results. Finally, weight at baseline was self-
reported because the majority of the hip fracture patients
were bedridden at baseline.
We conclude that the additional costs of our nutritional
intervention were very low as compared with the total costs.
With respect to weight as outcome, the nutritional interven-
tion was likely to be cost-effective. The probability that the
nutritional intervention was cost-effective for QALYs was
relatively low. Future research should incorporate other
outcome measures which are more appropriate for cost-
effectiveness evaluations in elderly patients, such as function-
al limitations, and other outcome parameters relevant for the
elderly. Furthermore, effectiveness evaluations should be ac-
companied with economic and cost-effectiveness evaluations.
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